Management of Embolic Stroke of Undetermined Source (ESUS)

被引：16
|
作者：
Geisler, Tobias [1 ]
Mengel, Annerose [2 ]
Ziemann, Ulf [2 ]
Poli, Sven [2 ]
机构：
[1] Univ Hosp Tubingen, Dept Cardiol, Otfried Muller Str 10, D-72076 Tubingen, Germany
[2] Univ Hosp Tubingen, Dept Neurol & Stroke, Hoppe Seyler Str 3, D-72076 Tubingen, Germany
来源：
DRUGS | 2018年 / 78卷 / 08期
关键词：
TRANSIENT ISCHEMIC ATTACK; PATENT FORAMEN OVALE; ATRIAL-FIBRILLATION; CRYPTOGENIC STROKE; SUBGROUP ANALYSIS; MINOR STROKE; ANTIPLATELET THERAPY; ORAL ANTICOAGULANTS; YOUNG-ADULTS; DOUBLE-BLIND;
D O I：
10.1007/s40265-018-0912-8
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
According to the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) classification, embolic stroke of undetermined source (ESUS) has refined the old definition of cryptogenic stroke. More sophisticated criteria and a well-defined diagnostic workup point out the embolic nature of this disease. Because ESUS is associated with a high stroke recurrence, a clear risk prediction and management is of utmost importance to improve prognosis. To date, standard pharmacotherapy consists of antiplatelet drugs and statins. This review attempts to provide an overview on the diagnostic criteria, prognosis, and current clinical trials evaluating the value of direct oral anticoagulants for secondary prevention after ESUS.
引用
收藏
页码：823 / 831
页数：9
相关论文
共 50 条
  • [1] Management of Embolic Stroke of Undetermined Source (ESUS)
    Tobias Geisler
    Annerose Mengel
    Ulf Ziemann
    Sven Poli
    [J]. Drugs, 2018, 78 : 823 - 831
  • [2] ESUS (embolic stroke of undetermined source) in the young
    Ladeira, A. F.
    Caetano, A.
    Barbosa, A. R.
    Mendonca, M.
    Calado, S.
    Viana-Baptista, M.
    [J]. CEREBROVASCULAR DISEASES, 2015, 39 : 58 - 58
  • [3] Endothelial dysfunction in embolic stroke of undetermined source (ESUS)
    Shirai, Y.
    Toi, S.
    Kubota, M.
    Adachi, U.
    Kitagawa, K.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 996 - 996
  • [4] Embolic stroke of undetermined source (ESUS) Classification of a new stroke entity
    Kitsiou, Alkisti
    Zuhorn, Frederic
    Wachter, Rolf
    Israel, Carsten Walter
    Schaebitz, Wolf-Rudiger
    Rogalewski, Andreas
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2021, 146 (06) : 403 - 409
  • [5] Frequency and Features of Patients with Embolic Stroke of Undetermined Source(ESUS)
    Perera, K. S.
    Vanassche, T.
    Mattina, K.
    Giruparajah, M.
    Bosch, J.
    Connolly, S.
    Hart, R.
    [J]. STROKE, 2014, 45 (12) : E267 - E268
  • [6] Endothelial Function is Impaired in Embolic Stroke of Undetermined Source (ESUS)
    Shirai, Yuka
    Toi, Sono
    Kubota, Megumi
    Adachi, Utako
    Kitagawa, Kazuo
    [J]. STROKE, 2018, 49
  • [7] ESUS („embolic stroke of undetermined source“)Wie viel Monitoring ist nötig?Embolic stroke of undetermined source (ESUS)How much monitoring is necessary?
    T. Stegmann
    R. Wachter
    W.‑R. Schäbitz
    [J]. Herz, 2019, 44 : 289 - 295
  • [8] Secondary Stroke Prevention in Cryptogenic Stroke and Embolic Stroke of Undetermined Source (ESUS)
    Diener, Hans-Christoph
    Bernstein, Richard
    Hart, Robert
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2017, 17 (09)
  • [9] Secondary Stroke Prevention in Cryptogenic Stroke and Embolic Stroke of Undetermined Source (ESUS)
    Hans-Christoph Diener
    Richard Bernstein
    Robert Hart
    [J]. Current Neurology and Neuroscience Reports, 2017, 17
  • [10] Longitudinal Study of Young Patients With Embolic Stroke of Undetermined Source (ESUS).
    Lee, Sarah
    MacLellan, Adam
    Ameriso, Sebastian F.
    Arauz, Antonio
    Hausler, Karl G.
    Arnold, Marcel
    Birnbaum, Lee A.
    Marti-Fabregas, Joan
    Olavarria, Veronica V.
    Taylor, Amanda
    Perera, Kanjana S.
    [J]. STROKE, 2019, 50
12345